Clinical Trial Update: Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A [Phase 3]

View source ↗

Summary

Phase 3 clinical study completed evaluating PK, efficacy, and safety of Wilate in patients with severe hemophilia A, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Wilate (von Willebrand factor/factor VIII concentrate)

Snippet

Sponsor: Octapharma | Conditions: Severe Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2019-12-03